<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>William R. Kelce - Derm Defense Inc.</title>
	<atom:link href="https://dermdefenseinc.com/tag/william-r-kelce/feed/" rel="self" type="application/rss+xml" />
	<link>https://dermdefenseinc.com</link>
	<description>A Biotechnology Company</description>
	<lastBuildDate>Thu, 31 Oct 2024 01:25:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.6</generator>

<image>
	<url>https://dermdefenseinc.com/wp-content/uploads/2022/12/cropped-DermDefenseInc-500-×-500-px-32x32.jpg</url>
	<title>William R. Kelce - Derm Defense Inc.</title>
	<link>https://dermdefenseinc.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>William R. Kelce, MS, PhD, ATS</title>
		<link>https://dermdefenseinc.com/2022/11/02/william-r-kelce/</link>
		
		<dc:creator><![CDATA[jennifer]]></dc:creator>
		<pubDate>Wed, 02 Nov 2022 14:47:10 +0000</pubDate>
				<category><![CDATA[Regulatory Team]]></category>
		<category><![CDATA[DermDefense Inc]]></category>
		<category><![CDATA[DermDefense Regulatory Team]]></category>
		<category><![CDATA[William R. Kelce]]></category>
		<guid isPermaLink="false">https://dermdefenseinc.com/?p=2062</guid>

					<description><![CDATA[<p>Regulatory Officer</p>
<p>The post <a href="https://dermdefenseinc.com/2022/11/02/william-r-kelce/">William R. Kelce, MS, PhD, ATS</a> first appeared on <a href="https://dermdefenseinc.com">Derm Defense Inc.</a>.</p>]]></description>
										<content:encoded><![CDATA[<h3 class="wp-block-heading"><strong>Regulatory Officer</strong></h3>



<p>William R. Kelce has more than twenty-five years of experience in the pharmaceutical and biopharmaceutical industry as an executive providing regulatory strategy and non-clinical development expertise. His Ph.D. and Post-Doctoral training in toxicology were completed at the University of Missouri-Columbia and The Johns Hopkins University, respectively.</p>



<p>Dr. Kelce has secured over $20 million in grant funding through 2020 for clients in the wound healing field with the following areas of expertise:</p>



<ul class="wp-block-list">
<li>Drug discovery and development program design focused on go/no-go decision-making.</li>



<li>Due diligence assessments for potential in-licensing and out-licensing candidates.</li>



<li>Diverse therapeutic area expertise including dermatology and wound healing.</li>
</ul>



<p>Dr. Kelce has been an active Fellow of the Academy of Toxicological Sciences since 1999.</p>



<h4 class="wp-block-heading">Video: Animal Rule, Priority Review Vouchers</h4>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe title="Part 6: Animal Rule, Priority Review Vouchers" width="720" height="405" src="https://www.youtube.com/embed/S1lvpVpdaWk?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div></figure><p>The post <a href="https://dermdefenseinc.com/2022/11/02/william-r-kelce/">William R. Kelce, MS, PhD, ATS</a> first appeared on <a href="https://dermdefenseinc.com">Derm Defense Inc.</a>.</p>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
